(Q36992132)

17 August 2017

Cyclosporin A inhibits the growth of Cryptococcus neoformans in a murine model (English)

1 reference

17 August 2017

1 reference

Cryptococcus neoformans

1 reference

1 reference

C H Mody

1 reference

17 August 2017

G B Toews

series ordinal

1 reference

17 August 2017

M F Lipscomb

series ordinal

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 January 1988

1 reference

17 August 2017

Infection and Immunity

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

17 August 2017

7-12

1 reference

Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice.

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259224

Cyclosporin A inhibits Coccidioides immitis in vitro and in vivo

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259224

Cyclosporine: a new immunosuppressive agent for organ transplantation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259224

New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259224

Cyclosporine: experience with therapeutic monitoring

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259224

Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259224

Effects of cyclosporine in experimental cryptococcal meningitis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259224

Cyclosporine: a review of drug monitoring problems and presentation of a simple, accurate liquid chromatographic procedure that solves these problems

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259224

T-cell-independent macrophage activation in mice induced with rRNA from Listeria monocytogenes and dimethyldioctadecylammonium bromide

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259224

Antischistosomal effect of cyclosporin A: cure and prevention of mouse and rat schistosomiasis mansoni

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259224

Effects of the new anti-lymphocytic peptide cyclosporin A in animals

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259224

Biological effects of cyclosporin A: A new antilymphocytic agent

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259224

Prophylactic treatment of BALB/c mice with cyclosporine A and its analog B-5-49 enhances resistance to Leishmania major

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259224

Antimalarial activity of cyclosporin A.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259224

Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259224

Cryptococcal infections in patients with acquired immune deficiency syndrome

4 September 2018

1 reference

12 December 2020

Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infection

1 reference

12 December 2020

Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2

1 reference

12 December 2020

Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF

1 reference

12 December 2020

Granulocyte-alveolar-macrophage interaction in the pulmonary clearance of Staphylococcus aureus

1 reference

12 December 2020

Cyclosporin A inhibits the delayed-type hypersensitivity reaction: impaired production of early pro-inflammatory mediator(s)

1 reference

12 December 2020

Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens

1 reference

12 December 2020

Filaricidal effects of cyclosporin-A against Dipetalonema viteae in Mastomys natalensis

1 reference

12 December 2020

Cryptococcosis in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Cyclosporin A treatment of an induced attack in a chronic relapsing model of experimental allergic encephalomyelitis

1 reference

12 December 2020

Identifiers

1 reference

17 August 2017

PubMed publication ID

3275587

1 reference